These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31851120)

  • 21. Differences in N-linked glycosylation between human surfactant protein-B variants of the C or T allele at the single-nucleotide polymorphism at position 1580: implications for disease.
    Wang G; Christensen ND; Wigdahl B; Guttentag SH; Floros J
    Biochem J; 2003 Jan; 369(Pt 1):179-84. PubMed ID: 12356334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The C/A(-18) polymorphism in the surfactant protein B gene influences transcription and protein levels of surfactant protein B.
    Steagall WK; Lin JP; Moss J
    Am J Physiol Lung Cell Mol Physiol; 2007 Feb; 292(2):L448-53. PubMed ID: 17071721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitric oxide synthase-2 down-regulates surfactant protein-B expression and enhances endotoxin-induced lung injury in mice.
    Baron RM; Carvajal IM; Fredenburgh LE; Liu X; Porrata Y; Cullivan ML; Haley KJ; Sonna LA; De Sanctis GT; Ingenito EP; Perrella MA
    FASEB J; 2004 Aug; 18(11):1276-8. PubMed ID: 15208261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of genetic variation in surfactant protein B on severe lung injury in African American children.
    Dahmer MK; O'cain P; Patwari PP; Simpson P; Li SH; Halligan N; Quasney MW
    Crit Care Med; 2011 May; 39(5):1138-44. PubMed ID: 21283003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surfactant protein-A limits Ureaplasma-mediated lung inflammation in a murine pneumonia model.
    Famuyide ME; Hasday JD; Carter HC; Chesko KL; He JR; Viscardi RM
    Pediatr Res; 2009 Aug; 66(2):162-7. PubMed ID: 19390477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between surfactant protein B + 1580 polymorphism and the risk of respiratory failure in adults with community-acquired pneumonia.
    Quasney MW; Waterer GW; Dahmer MK; Kron GK; Zhang Q; Kessler LA; Wunderink RG
    Crit Care Med; 2004 May; 32(5):1115-9. PubMed ID: 15190959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rescue of SP-B knockout mice with a truncated SP-B proprotein. Function of the C-terminal propeptide.
    Akinbi HT; Breslin JS; Ikegami M; Iwamoto HS; Clark JC; Whitsett JA; Jobe AH; Weaver TE
    J Biol Chem; 1997 Apr; 272(15):9640-7. PubMed ID: 9092492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of lung surfactant protein B expression during Pneumocystis carinii pneumonia in mice.
    Beers MF; Atochina EN; Preston AM; Beck JM
    J Lab Clin Med; 1999 May; 133(5):423-33. PubMed ID: 10235125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Innate immune molecule surfactant protein D attenuates sepsis-induced acute kidney injury through modulating apoptosis and NFκB-mediated inflammation.
    Lu SJ; Xu JH; He ZF; Wu P; Ning C; Li HY
    Int Wound J; 2020 Feb; 17(1):100-106. PubMed ID: 31701658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival of Surfactant Protein-A1 and SP-A2 Transgenic Mice After
    Thorenoor N; Umstead TM; Zhang X; Phelps DS; Floros J
    Front Immunol; 2018; 9():2404. PubMed ID: 30459763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Surfactant Protein D in Experimental Otitis Media.
    Abdel-Razek O; Liu T; Chen X; Wang Q; Vanga G; Wang G
    J Innate Immun; 2021; 13(4):197-210. PubMed ID: 33556949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surfactant proteins A and D enhance pulmonary clearance of Pseudomonas aeruginosa.
    Giannoni E; Sawa T; Allen L; Wiener-Kronish J; Hawgood S
    Am J Respir Cell Mol Biol; 2006 Jun; 34(6):704-10. PubMed ID: 16456184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Featured Article: Electroporation-mediated gene delivery of surfactant protein B (SP-B) restores expression and improves survival in mouse model of SP-B deficiency.
    Barnett RC; Lin X; Barravecchia M; Norman RA; de Mesy Bentley KL; Fazal F; Young JL; Dean DA
    Exp Biol Med (Maywood); 2017 Jul; 242(13):1345-1354. PubMed ID: 28581337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptidylarginine Deiminases 2 Mediates Caspase-1-Associated Lethality in Pseudomonas aeruginosa Pneumonia-Induced Sepsis.
    Wu Z; Tian Y; Alam HB; Li P; Duan X; Williams AM; Liu B; Ma J; Li Y
    J Infect Dis; 2021 Mar; 223(6):1093-1102. PubMed ID: 32729925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Alterations of pulmonary surfactant during Pseudomonas aeruginosa pneumonia of immunocompromised rats].
    Li Z; Qu J; He L
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Apr; 24(4):204-7. PubMed ID: 11802963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Innate Immune Molecule Surfactant Protein D Attenuates Sepsis-induced Acute Pancreatic Injury through Modulating Apoptosis and NF-κB-mediated Inflammation.
    Liu Z; Shi Q; Liu J; Abdel-Razek O; Xu Y; Cooney RN; Wang G
    Sci Rep; 2015 Dec; 5():17798. PubMed ID: 26634656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-27 controls sepsis-induced impairment of lung antibacterial host defence.
    Cao J; Xu F; Lin S; Song Z; Zhang L; Luo P; Xu H; Li D; Zheng K; Ren G; Yin Y
    Thorax; 2014 Oct; 69(10):926-37. PubMed ID: 25074706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloid arginase-1 controls excessive inflammation and modulates T cell responses in Pseudomonas aeruginosa pneumonia.
    Haydar D; Gonzalez R; Garvy BA; Garneau-Tsodikova S; Thamban Chandrika N; Bocklage TJ; Feola DJ
    Immunobiology; 2021 Jan; 226(1):152034. PubMed ID: 33278710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Enhancer-Binding Protein MifR, an Essential Regulator of α-Ketoglutarate Transport, Is Required for Full Virulence of Pseudomonas aeruginosa PAO1 in a Mouse Model of Pneumonia.
    Xiong W; Perna A; Jacob IB; Lundgren BR; Wang G
    Infect Immun; 2022 Oct; 90(10):e0013622. PubMed ID: 36125307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia.
    Shindo Y; Fuchs AG; Davis CG; Eitas T; Unsinger J; Burnham CD; Green JM; Morre M; Bochicchio GV; Hotchkiss RS
    J Leukoc Biol; 2017 Feb; 101(2):543-554. PubMed ID: 27630218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.